A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants

Abstract See Lemke (doi:10.1093/brain/awaa079) for a scientific commentary on this article. Many rare and severe neurodevelopmental disorders are caused by de novo variants, but epidemiological estimates are available for very few of these disorders. Using a statistical approach based on genetic data, López-Rivera et al. provide more than 3000 incidence estimates for disorders caused by de novo variants.

[1]  Chaipat Chunharas,et al.  TTTCA repeat insertions in an intron of YEATS2 in benign adult familial myoclonic epilepsy type 4. , 2019, Brain : a journal of neurology.

[2]  Thomas Bourgeron,et al.  Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3 , 2019, Nature Communications.

[3]  D. Pilz,et al.  Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort , 2019, Brain : a journal of neurology.

[4]  G. Carvill,et al.  Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy , 2019, Epilepsia open.

[5]  Ryan L. Collins,et al.  Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes , 2019, bioRxiv.

[6]  G. Carvill,et al.  Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies. , 2018, American journal of human genetics.

[7]  Y. Huang,et al.  TTTCA repeat expansion causes familial cortical myoclonic tremor with epilepsy , 2018, European journal of neurology.

[8]  Edward R. Smith,et al.  De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus , 2018, Neuron.

[9]  M. Daly,et al.  De novo variants in neurodevelopmental disorders with epilepsy , 2018, Nature Genetics.

[10]  Joshua S. Paul,et al.  Prevalence and properties of intragenic copy-number variation in Mendelian disease genes , 2018, Genetics in Medicine.

[11]  Amanda S. Lindy,et al.  Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders , 2018, Epilepsia.

[12]  S. Auvin,et al.  The Problem of Rarity: Estimation of Prevalence in Rare Disease. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  S. Sugano,et al.  Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy , 2018, Nature Genetics.

[14]  Bradley P. Coe,et al.  Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications , 2017, Genome Medicine.

[15]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[16]  J. Rosenfeld,et al.  High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. , 2017, American journal of human genetics.

[17]  Yufeng Shen,et al.  Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands , 2017, Nature Genetics.

[18]  G. Shaw,et al.  Fetal de novo mutations and preterm birth , 2017, PLoS genetics.

[19]  P. Stenson,et al.  The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies , 2017, Human Genetics.

[20]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[21]  Robert Cook-Deegan,et al.  Public variant databases: liability? , 2016, Genetics in Medicine.

[22]  Xing-Ming Zhao,et al.  OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines , 2016, Nucleic Acids Res..

[23]  K. Fujikura,et al.  Global Carrier Rates of Rare Inherited Disorders Using Population Exome Sequences , 2016, PloS one.

[24]  P. Striano,et al.  STXBP1 encephalopathy , 2016, Neurology.

[25]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[26]  P. Striano,et al.  The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome , 2015, Epilepsia.

[27]  Eileen M. Walsh,et al.  Incidence of Dravet Syndrome in a US Population , 2015, Pediatrics.

[28]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[29]  J. Shendure,et al.  The origins, determinants, and consequences of human mutations , 2015, Science.

[30]  Steven J. Schrodi,et al.  Prevalence estimation for monogenic autosomal recessive diseases using population-based genetic data , 2015, Human Genetics.

[31]  Allan Bayat,et al.  The incidence of SCN1A‐related Dravet syndrome in Denmark is 1:22,000: A population‐based study from 2004 to 2009 , 2015, Epilepsia.

[32]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[33]  E. Garne,et al.  Holt Oram syndrome: a registry-based study in Europe , 2014, Orphanet Journal of Rare Diseases.

[34]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[35]  L. Vissers,et al.  Point mutations as a source of de novo genetic disease. , 2013, Current opinion in genetics & development.

[36]  P. Keightley,et al.  A Comparison of Models to Infer the Distribution of Fitness Effects of New Mutations , 2013, Genetics.

[37]  J. Lacaille,et al.  Intellectual disability without epilepsy associated with STXBP1 disruption , 2011, European Journal of Human Genetics.

[38]  E. Fombonne,et al.  De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy , 2009, Annals of neurology.

[39]  S. Groft,et al.  Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data. , 2017, Advances in experimental medicine and biology.

[40]  P. Bork,et al.  OGEE v 2 : an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines , 2016 .

[41]  I. Arroyo Carrera,et al.  [The Townes-Brocks syndrome in Spain: the epidemiological aspects in a consecutive series of cases]. , 1999, Anales espanoles de pediatria.